期刊文献+

腺病毒介导的AT2R基因转染对大鼠颈动脉新生内膜增生的抑制作用 被引量:1

Inhibition of neointimal hyperplasia after balloon angioplasty of carotid artery with transfection of adenovirus-mediated AT2R gene in rat
暂未订购
导出
摘要 目的构建AngⅡ2型受体(AT2R)重组腺病毒载体,并研究AT2R基因转染对大鼠颈动脉新生内膜增生的影响。方法用细菌内同源重组方法构建带有绿色荧光蛋白(GFP)报告基因的AT2R重组腺病毒载体pAdCMV/AT2R。大鼠颈动脉球囊损伤后,将pAdCMV/AT2R或空病毒pAdGFP局部导入,分别用RTPCR、免疫荧光染色、激光共聚焦技术检测目的基因AT2RmRNA及蛋白在血管中的表达,利用图像分析仪进行组织形态学分析。结果重组腺病毒载体pAdCMV/AT2R经PCR鉴定正确,其滴度为1.5×1012pfu/ml。pAdCMV/AT2R局部转染后14天,大鼠颈动脉新生内膜、外膜、中层有绿色荧光,阳性面积约40%;转染后7、14、21天大鼠颈动脉AT2RmRNA及蛋白表达显著高于pAdGFP转染组,21天时其内膜与中层的面积比显著低于pAdGFP组(0.78±0.06vs1.36±0.21,P<0.01)。结论pAdCMV/AT2R在体转染能上调血管中AT2R的表达,显著抑制大鼠颈动脉球囊损伤后新生内膜增生。 Objective the construct the recombinant adenovirus of Angiotensin Ⅱ type 2 receptor (AT2R). and study the effect of AT2R on prevention of neointimal hyperplasia in rat carotid arteries after balloon angioplasty. Methods The recombinant adenovirus of AT2R with green fluorescent protein was constructed by using the method of homogenous recombination in bacteria. AT2R gene was transduced into rat carotid arteries with pAdCMV/AT2R after the reproduction of rat carotid balloon injury restenosis model. The expression and the transfection efficiency of AT2R gene were evaluated by RTPCR, immunofluorescence staining, and confocal microscope. The intimal/medial area ratio was measured by digital analysis system. Results The titre of purified recombinant adenovirus was 1.5 × 10^12 pfu ml, and it was proved by PCR. pAdCMV/AT2R transfection efficiency in carotid artery was about 40% at day14, and localized to the neointima, as well as to the media and the adventitia, pAdCMV/AT 2R delivered into injured rat carotid arteries significantly up-regulated AT2RmRNA and protein expression in neointima from day 7 to 21 after injury. Compared with pAd GFP transfection group, pAdCMV AT2R transfection reduced I/M ratio significantly on day 21(0.78±0.06 vs. 1.36±0.21 respectively, P〈0.01). Conclusion Adenovirus-mediated gene transfer of AT2R significantly up-regulate AT 2RmRNA and protein expression in neointima and effectively inhibit neointimal hyperplasia in the rat carotid arteries after balloon angioptasty. It may potentially be developed as a new approach to prevent restenosis after angioptasty.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2005年第12期1068-1071,共4页 Medical Journal of Chinese People's Liberation Army
关键词 受体 血管紧张素 2型 转染 血管内膜 receptor, angiotensin, type 2 transfection tunica intima
  • 相关文献

参考文献9

  • 1Hoeven BL, Pires NM, Warda HM et al. Drug-eluting stents: results, promises and problems. Int J Cardiol,2005,99(1):9.
  • 2刘建平,何国祥,景涛,王旭,史光鉴.腺病毒介导血管紧张素Ⅱ2型受体基因转染对血管平滑肌细胞生物学行为的影响[J].解放军医学杂志,2001,26(6):441-444. 被引量:2
  • 3Zeng M, Smith SK, Siegel F et al. AdEasy system made easier by lecting the viral backbone plasmid preceding homologous recombination. Biotechniques,2001,31(2):260.
  • 4He TC, Zhou S, Costa da L et al. A simplified system for generating recombinat adenoviruses. Proc Natl Acad Sci USA,1998,95(5):2509.
  • 5Kopp CW, de Martin R. Gene therapy approaches for the prevention of restenosis.Curr Vasc Pharmacol,2004,2(2):183.
  • 6Baum BJ, Goldsmith CM, Kok MR et al. Advances in vector-mediated gene transfer. Immunol Lett, 2003,90(2-3):145.
  • 7Karthikeyan G, Bhargava B. Prevention of restenosis after coronary angioplasty. Curr Opin Cardiol,2004,19(5):500.
  • 8Annegret B, Elena K, Thomas U. Angiotensin Ⅱ type 2 receptors: signalling and pathophysiological role. Curr Opin Ephrol Hyper,2001,10:239.
  • 9Matsubara H. Angiotensin Ⅱ type 2 (AT2) receptor signal and cardiovascular action. Nippon Yakurigaku Zasshi,2002,119:99.

二级参考文献7

  • 1[1]Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res, 1998,83:1182
  • 2[2]Horiuchi M, Akishita M, Dzau VJ. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hyprtension, 1999,33:613
  • 3[3]Matrougui K, Loufrani L, Heymes C et al. Activation of AT2 receptors by endogenous angiotensin II is involved in flow-induced dilation in rat resistance arteries. Hypertension,1999,34: 659
  • 4[4]Akishita M, Horiuchi M, Yamada H et al. Accentuated vascular proliferation and altered remodeling after injury in mice lacking angiotensin II type 2 receptor. Circulation, 1997,96(suppl I):547(Abstract)
  • 5[5]Nozawa Y, Matsuura N, Miyake H et al. Effects of TH-142177 on angiotensin Ⅱ-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury. Life Science,1999,64:2061
  • 6[6]Miura S, Karnik SS. Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis. EMBO J, 2000, 19(15):4026
  • 7[7]Lehtonen JY, Daviet L, Nahmias C et al. Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis. Mol Endocrinol, 1999,13(7): 1051

共引文献1

同被引文献9

  • 1Wei-guo Z, Hui Y, Shan L, et al. PPAR-gamma agonist inhibits Ang II-induced activation of dendritic cells via the MAPK and NF-kappaB pathways [J]. Immunol Cell Biol, 2010, 88(3): 305-312.
  • 2Yang L, Du C, Chen T, et al. Distinct MAPK pathways are involved in IL-23 production in dendritic cells cocul- tured with NK cells in the absence or presence of angioten- sin II [J]. Mol Immunol, 2012, 51(1): 51-56.
  • 3Inaba K, Inaba M, Romani N, et al. Generation of large number of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony2 stimu- lating factor [J]. J Exp Med, 1992, 176:1 693-702.
  • 4Brugts J J, van Vark L, Akkerhuis M, et al. Impact of re- nin-angiotensin system inhibitors on mortality and major cardiovascular endpoints in hypertension: a number-nee- ded-to-treat analysis [J]. Int J Cardiol, 2014, 181C: 425-429.
  • 5Nahmod K, Gentilini C, Vermeulen M. Impaired function of dendritic ceils deficient in angiotensin I1 type 1 recep- tors [J]. J Pharmacol Exp Ther, 2010, 334 (3) : 854-862.
  • 6Matavelli LC, Zatz R, Siragy HM. A nonpeptide angioten- sin II type2 receptor agonist prevents renal inflammation in early diabetes [J]. J Cardiovasc Pharmacol, 2015, 14: 223-230.
  • 7Chen C, Meng Y, Wang L. Ubiquitin-activating enzyme E1 inhibitor PYR41 attenuates angiotensin II -induced acti- vation of dendritic ceils via the IKBa/NF-κB and MKP1/ ERK/STAT1 pathways[J]. Immunology, 2014, 23 ( 1 ) : 457-462.
  • 8Harrison DG, Marvar PJ, Titze JM. Vascular inflammato- ry cells in hypertension [J]. Front Physiol, 2012, 7(3) : 128.
  • 9许增祥,谢闵,唐雅玲,王双,杨永宗.氧化修饰高密度脂蛋白促进C57BL/6J小鼠骨髓源性树突状细胞成熟活化[J].中国动脉硬化杂志,2009,17(1):39-42. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部